Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
Luye Pharma Group is a pharmaceutical company focused on drugs and complex formulations.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New pill could make IVF easier and more effective
Disease control OngoingThis phase 2 trial tests an oral drug called LY01021 in about 90 women undergoing IVF or ICSI. The drug aims to prevent premature hormone surges that can disrupt egg retrieval. Researchers are testing three doses to find the best balance of effectiveness and safety, with the goal…
Phase 2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New depression pill gets first human safety check
Symptom relief By invitation onlyThis early-stage study tests a new tablet called LY03021 in 98 healthy adults aged 18 to 45. The main goal is to check safety and how the body processes the drug. It is a first step before testing the drug in people with depression.
Phase 1 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Breakfast or not? new study tests Food's impact on brain drug
Knowledge-focused OngoingThis early-stage trial is testing how eating food changes the way the body absorbs a new experimental drug called LY03020. The drug is being developed for schizophrenia and psychosis related to Alzheimer's disease. Sixteen healthy volunteers will take the drug once with food and …
Phase 1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC